Preloader

Orchidia Pharma

At Orchidia Pharma, we blend innovation with integrity to deliver high-quality pharmaceutical care. Our mission is to improve health outcomes—one patient, one solution at a time.

Who We Are

Orchidia Pharma

At Orchidia Pharma, we blend innovation with integrity to deliver high-quality pharmaceutical care. Our mission is to improve health outcomes—one patient, one solution at a time.

Why Orchidia

Orchidia Pharma

At Orchidia Pharma, we blend innovation with integrity to deliver high-quality pharmaceutical care. Our mission is to improve health outcomes—one patient, one solution at a time.

History

Orchidia Pharma

Orchidia Pharma boasts a rich history since its establishment in 2007 as a fully integrated export-oriented pharmaceutical company.

  • Our Vision is to become a global value creator in healthcare
  • We are dedicated to developing and producing specialized, high-quality healthcare products
  • We continuously seek new and better ways to address healthcare challenges.
WHAT WE OFFER

Discover Our Health Care Products

Opthalmic

Opthalmic

Our current portfolio includes 60 ophthalmic drugs, and 8 medical devices obtain the CE marked certificates.

Raed More
Cosmeceutical

Cosmeceutical

In addition to a rich pipeline of 60 drugs in different ophthalmic drug forms. Our CE products are registered in Germany; our authorized representative there is MDSS( Medical Device Safety Services)

Raed More
Food

Food

We also have a portfolio of 20 food supplement and 56 cosmeceutical products, manufactured according to the latest technologies.

Raed More

Contact Us

Orchidia was established in 2007 with a distinguished mission of improving people’s Quality of Life

  • Phone :

    0244891235

  • Address :

    Al-Obour city – Industrial Zone, Area 14,15, Block no.12011, Cairo, Egypt.

  • Mail :

    info@orchidiapharmaceutical.com

Please contact our reception for any enquiries; our doctors will handle urgent calls.

Orchidia is a leading ophthalmic manufacturer in Egypt, ranked #2 among 45 companies in the market